Novartis AG (NYSE:NVS)
| 96.32 Delayed Data As of Dec 08 |  +0.015 / +0.02%Today’s Change | 75.68 Today|||52-Week Range 99.94 | +12.20% Year-to-Date |
Latest NVS News | Press Releases
| This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks Dec 10 / MotleyFool.com - Paid Partner Content | Why Is Pfizer (PFE) Down 1.4% Since Last Earnings Report? Nov 30 / Zacks.com - Paid Partner Content |
| Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod Dec 08 / Zacks.com - Paid Partner Content | CAR T-Cell Therapies Under FDA Watch on Reports of Malignancies Nov 29 / Zacks.com - Paid Partner Content |
| Novartis (NVS) Gets FDA Nod for Rare Blood Disorder Drug Dec 06 / Zacks.com - Paid Partner Content | Novartis (NVS) Raises Mid-Term Sales Outlook; Outlines Strategy Nov 28 / Zacks.com - Paid Partner Content |
| Pharma Stock Roundup: ABBV to Buy Immunogen, NVS Ups Mid-Term Sales View & More Dec 01 / Zacks.com - Paid Partner Content | 3 Large Drug Stocks That Have Outperformed Industry YTD Nov 28 / Zacks.com - Paid Partner Content |
